Leo de Leede

InnoCore Technologies BV develops drug delivery technologies. It serves the pharmaceutical and medical device industry by developing and manufacturing innovative drug delivery systems that enhance their products. The company was founded by Theodorus Adrianus Cornelius Flipsen and Rob Steendam in 2004 and is headquartered in Groningen, the Netherlands.

Polyganics BV engages in the development, manufacture, and commercialization of bioresorbable medical devices that facilitate tissue repair and regeneration. It offers pipeline, peripheral nerve repair, neurosurgery, and general surgery products . The company was founded in 1999 and is headquartered in Groningen, the Netherlands.

PolyVation BV provides research, development, custom synthesis, and manufacturing services relating to polymers for biomedical and pharmaceutical applications. The firm performs biocompatibility research such as review, planning, rationales, physico-chemical, and biological tests. It also offers vinyl pyrolidone, acrylate, and silicone. The company was founded by Theodorus Adrianus Cornelius Flipsen in 1996 and is headquartered in Groningen, the Netherlands.

Neurendo BV develops novel polymer-based trocars. Its products are used in neuro surgical procedures. The firm provides shafts which are used to fix skulls. The company is headquartered in Groningen, the Netherlands.

Xenikos BV focuses on the development of immunotherapies for the treatment of patients suffering from immune diseases. It is developing a combination of two toxin-loaded anti-T-cell antibodies, T-Guard, as a therapeutic tool for resetting the body's immune system in T-cell mediated diseases. The company was founded by Ypek van Oosterhout in September 2009 and is headquartered in Nijmegen, the Netherlands.

Baliopharm GmbH operates as biotechnology company. It develops a novel therapeutics for the treatment of autoimmune diseases like rheumatoid arthritis, Crohn`s disease, psoriasis and multiple sclerosis, and for cancer. The company was founded in 2011 and is headquartered in Juelich, Germany.

Atriva Therapeutics GmbH is a biopharmaceutical company that develops host-targeting antiviral therapies. It focuses on the development of new antiviral therapies against different respiratory viral infections. The company was founded by Rainer Lichtenberger and Henrik Luer Lueßen in April 2015 and is headquartered in Tuebingen, Germany.

Pharma Connect Capital BV is a private equity firm with headquarters in Groningen, the Netherlands. It was founded in 2017.